-
- Service Offerings
- Managed Market Analysis
- Education and Training
- Competitive Intelligence
- Expanded Access
- Case Studies
- Comparative Effectiveness Review - Diabetes
- Expanded Access
- Comparative Cost Analysis - Pharmaceuticals
- Healthcare Reform Analysis
- Health Technology Assessment - Oncology
- Reimbursement Call Center and Patient Assistance Program Design - Multiple Product Classes
- Reimbursement Training and Field Reimbursement Call Tracking Tool
- Competitive Intelligence - Urology
- Product Commercialization and Reimbursement Landscape Analysis - Oncology
- Clinical Services Evaluation - Specialty Pharmacy
- Commercialization Strategy - Deep Vein Thrombosis
- Coverage Analysis - Drug Delivery System
- Reimbursement Coverage and Coding Analysis - Vascular Stents
- Health Economic Analysis - Rheumatoid Arthritis
- Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
- Comprehensive Clinical Analysis and Clinical Protocol Design - Migrane
- Outcomes Research Plan - Gastroenterology
- Clinical Compendium and Gap Analysis - Pain Management
- Reimbursement Landscape Analysis - Rare Bleeding Disorders (Hemophilia)
- Disease Area Review and Burden of Illness Analysis - Oncology
- Hospital Inpatient Payor Claims Analysis - Hospital Acquired Infections
- Health Economic Analysis - Orthopedics
- Market Valuation - Opioids
- Meta Analysis - HIV (Human Immunodeficiency Virus)
- AMCP Dossier - Dermatology
- Competitive Intelligence - Infectious Diseases
- Competitive Intelligence - Contraception
- Reimbursement Landscape Analysis - Urology
- Health Economics Analysis - Crohn's Disease
- Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
- Patient Assistance Program Design - Insulin Products
- Health Technology Assessment - Wound Therapy System
Case Studies
AMCP Dossier - Dermatology
Insight
A leading pharmaceutical company specializing in skin care engaged The Aequitas Group to submit a dossier, using the Academy of Managed Care Pharmacy (AMCP) format¸ for their new acne product.
Strategy
In order to further define the value proposition of the product, The Aequitas Group created a dossier describing the cost of illness and limitations of current therapy while presenting clear, data-driven arguments that would achieve favorable formulary status and maintain competitive pricing in the managed markets.
Execution
By including pertinent supporting clinical and economic information derived from an extensive literature synthesis, the research team was able to demonstrate a cost-effectiveness model and budget impact analysis of the client’s new product relative to their competitors.
© 2009 The Aequitas Group, Inc. All Rights Reserved.